LEVILACTOBACILLUS BREVIS
UNII 268IL53Q7O

Substance Identification & Data

This profile provides standardized clinical and technical data for Levilactobacillus Brevis, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 268IL53Q7O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 2377030. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
268IL53Q7O
CAS Registry Number
N/A
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
LEVILACTOBACILLUS BREVIS
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
268IL53Q7O
The specific atomic composition represented as a molecular structure string.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
962781
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
1580
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levilactobacillus Brevis. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BACILLUS CASEI G WHOLE
BACILLUS G WHOLE
BETABACTERIUM BREVE WHOLE
LACTOBACILLUS BREVIS
LACTOBACILLUS BREVIS [WHO-DD]
LACTOBACTERIUM BREVE WHOLE
LEVILACTOBACILLUS BREVIS

Systematic Nomenclature

LACTOBACILLUS BREVIS WHOLE
LEVILACTOBACILLUS BREVIS (ORLA-JENSEN, 1919) ZHENG ET AL. 2020

NDC Products Containing LEVILACTOBACILLUS BREVIS

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: